Royal Bank Of Canada Recursion Pharmaceuticals, Inc. Transaction History

Royal Bank Of Canada

$471 Billion
Q3 2024

A detailed history of Royal Bank Of Canada transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Royal Bank Of Canada holds 45,332 shares of RXRX stock, worth $267,005. This represents 0.0% of its overall portfolio holdings.

Number of Shares

45,332

Previous 49,735 8.85%

Holding current value

$267,005

Previous $373,000 20.11%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$5.92 - $8.6 $26,065 - $37,865	-4,403 Reduced 8.85%	45,332 $298,000
Q2 2024 Aug 14, 2024	BUY	$7.35 - $10.05 $250,826 - $342,966	34,126 Added 218.63%	49,735 $373,000
Q1 2024 Nov 05, 2024	SELL	$9.13 - $15.52 $311,570 - $529,635	-34,126 Reduced 68.62%	15,609 $155,000
Q1 2024 May 15, 2024	SELL	$9.13 - $15.52 $168,503 - $286,437	-18,456 Reduced 54.18%	15,609 $155,000
Q4 2023 Feb 14, 2024	BUY	$5.09 - $10.79 $40,211 - $85,241	7,900 Added 30.19%	34,065 $335,000
Q3 2023 Nov 14, 2023	BUY	$6.59 - $15.86 $76,944 - $185,181	11,676 Added 80.59%	26,165 $200,000
Q2 2023 Aug 14, 2023	BUY	$4.56 - $9.94 $30,009 - $65,415	6,581 Added 83.22%	14,489 $108,000
Q1 2023 May 15, 2023	SELL	$6.42 - $9.64 $93,096 - $139,789	-14,501 Reduced 64.71%	7,908 $52,000
Q4 2022 Feb 14, 2023	BUY	$7.16 - $12.7 $146,507 - $259,867	20,462 Added 1050.95%	22,409 $172,000
Q3 2022 Nov 14, 2022	BUY	$7.83 - $13.6 $7,321 - $12,716	935 Added 92.39%	1,947 $21,000
Q2 2022 Aug 15, 2022	SELL	$5.04 - $9.26 $30,587 - $56,198	-6,069 Reduced 85.71%	1,012 $8,000
Q1 2022 May 16, 2022	SELL	$6.16 - $18.03 $109,167 - $319,527	-17,722 Reduced 71.45%	7,081 $51,000
Q4 2021 Feb 14, 2022	BUY	$16.14 - $21.86 $354,337 - $479,914	21,954 Added 770.59%	24,803 $425,000
Q3 2021 Nov 15, 2021	BUY	$19.03 - $41.33 $26,718 - $58,027	1,404 Added 97.16%	2,849 $65,000
Q2 2021 Aug 16, 2021	BUY	$18.0 - $37.42 $26,010 - $54,071	1,445 New	1,445 $53,000

Others Institutions Holding RXRX

# of Institutions

287

Shares Held

242M

Call Options Held

1.35M

Put Options Held

2.32M

View Full List

About RECURSION PHARMACEUTICALS, INC.

Ticker RXRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 180,480,000
Market Cap $1.06B
Description
Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...

More about RXRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

News

Stay updated on Royal Bank Of Canada with notifications on news.

Account

Royal Bank Of Canada Recursion Pharmaceuticals, Inc. Transaction History